#1 Botox Alternative
(1) 30 ml bottle
|
Bioque Serum XL is a daily, non-toxic, injection-free substitute for Botox. Useful for elimination of facial lines and wrinkles. Order Toll Free (888) 566-5642.
| PRODUCT | MORE INFO | PRICE | ORDER |
|---|---|---|---|
| 30 ml gel | 1 bottle | $85.00 |  |
* These celebrities have been associated with products we sell, or specific ingredients contained within our products. This does not imply that they either endorse or promote any of these products unless otherwise specified.
Bioque Serum XL Ingredient Facts
Bioque Serum XL Success Stories
Bioque Serum XL contains 20% Argireline, the highest concentration of this facial muscle relaxant available today. Argireline is useful to relax facial muscles and diminsh appearance of fine lines and wrinkles.
* The preceding testimonials are actual quotes from our Bioque Serum XL customers.
Reduce Wrinkles and Facial Lines
Relevant Article 1
Bioque Serum XL is a non-toxic, injection-free substitute for Botox. It is a facial muscle relaxant that's used to eliminate facial lines and wrinkles caused by excessive pressure of the facial muscles.
Celebrity Citings
The Bioque Serum XL facial muscle relaxant works very much like Botox in that it penetrates your facial skin and prevents the severe muscle contractions that reveal facial wrinkles. Bioque Serum XL also contains ingredients that promote the production of collagen in your skin which results in firmer, less wrinkled skin.
US Celebs Using Bioque Serum XL
The US celebs have come to their senses and started to jump on a different bandwagon. That is the bandwagon of the cult range, Bioque. Bioque’s Serum XL is a botox cream that can be applied daily and gives the same benefits as botox. The peptides in Serum XL freeze the muscles and allow them to smooth out, naturally erasing wrinkles and fine lines without the needles and without leaving you with an emotionless face and an empty pocket. Julia Roberts, Sarah Jessica Parker and Kim Cattrall are all fans of Serum XL and look younger then ever.
PR Web - March 6, 2004